DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Richardson PG, Barlogie B, Berenson J. et al.
A phase 2 study of bortezomib in relapsed, refractory myeloma.
N Engl J Med 2003; 348: 2609-2617
We do not assume any responsibility for the contents of the web pages of other providers.